US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Autonomix Medical Inc

0.4327

-0.0005-0.12%

Post-market: 0.43270.00000.00%16:04 EDT

Volume:86.05K

Turnover:35.89K

Market Cap:4.94M

PE:-0.29

High:0.4327

Open:0.4245

Low:0.4050

Close:0.4332

52wk High:2.82

52wk Low:0.3415

Shares:11.41M

Float Shares:6.53M

Volume Ratio:0.69

T/O Rate:1.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5110

EPS(LYR):-6.4594

ROE:-188.75%

ROA:-98.98%

PB:0.58

PE(LYR):-0.07

Loading ...

Overview Company News Filings

Autonomix Medical CEO Brad Hauser to Present at LSI USA ’26

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

BRIEF-Autonomix Medical Announces Release Of New CEO Corner Segment

Autonomix Medical CEO Brad Hauser Highlights Publication Strategy and Scientific Validation

Autonomix Medical to Present Long-Term Pancreatic Cancer Pain Data at SSO 2026 Annual Meeting

Autonomix Medical Is Maintained at Buy by Maxim Group

Autonomix Medical Unveils Final Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at SIO 2026

Autonomix Medical Faces Nasdaq Delisting Risk Over Low Share Price

Autonomix showcases PoC study clinical data at 2026 ASCO Symposium

Autonomix Medical Reports Durable Pain Relief in Pancreatic Cancer Across All Stages

Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology

THOMSON REUTERS

Autonomix Medical Granted European Patent for Precision Nerve-Targeted Cardiac Therapies

Autonomix CEO Highlights IP Expansion and New Indications in Virtual Investor Segment

Autonomix Medical Showcases Long-Term Pancreatic Cancer Pain Study at 2026 ASCO Symposium

Autonomix files to sell 13.5M shares of common stock for holders

Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth

Autonomix prices 4.5M shares at $1.11 in private placement

Autonomix Medical Raises $5 Million in Private Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AMIX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMIX\",,,,,undefined,":{"symbol":"AMIX","market":"US","secType":"STK","nameCN":"Autonomix Medical Inc","latestPrice":0.4327,"timestamp":1774468800000,"preClose":0.4332,"halted":0,"volume":86052,"hourTrading":{"tag":"盘后","latestPrice":0.4327,"preClose":0.4327,"latestTime":"16:04 EDT","volume":144,"amount":62.3088,"timestamp":1774469088472,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.001154201292705449,"floatShares":6532500,"shares":11409344,"eps":-1.511,"marketStatus":"Post-Mkt","change":-0.0005,"latestTime":"03-25 16:20:30 EDT","open":0.4245,"high":0.4327,"low":0.405,"amount":35890.69533,"amplitude":0.063943,"askPrice":0.4702,"askSize":100,"bidPrice":0.4074,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-1.511,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1774483200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4332,"preHourTrading":{"tag":"盘前","latestPrice":0.4345,"preClose":0.4332,"latestTime":"09:29 EDT","volume":1210,"amount":512.0919892,"timestamp":1774445399999,"change":0.0013,"changeRate":0.003001,"amplitude":0.028393},"postHourTrading":{"tag":"盘后","latestPrice":0.4327,"preClose":0.4327,"latestTime":"16:04 EDT","volume":144,"amount":62.3088,"timestamp":1774469088472,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.689929},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMIX\",,,,,undefined,":{"symbol":"AMIX","floatShares":6532500,"roa":"-98.98%","roe":"-188.75%","lyrEps":-6.459374,"volumeRatio":0.689929,"shares":11409344,"dividePrice":0,"high":0.4327,"amplitude":0.063943,"preClose":0.4332,"low":0.405,"week52Low":0.3415,"pbRate":"0.58","week52High":2.82,"institutionHeld":0,"latestPrice":0.4327,"committee":-0.904762,"eps":-1.511,"divideRate":0,"volume":86052,"delay":0,"ttmEps":-1.511,"open":0.4245,"prevYearClose":0.55,"prevWeekClose":0.459,"prevMonthClose":0.4389,"prevQuarterClose":0.55,"fiveDayClose":0.459,"twentyDayClose":0.403,"sixtyDayClose":0.5754},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-10-25","symbol":"AMIX","defaultRemindTime":1729863000000,"type":"split","dateTimestamp":1729828800000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":2,"updateTime":1745985600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMIX","date":"2026-03-24","current":-0.278359,"percent":0.786948,"low":-13.446357,"twenty":-1.174185,"median":-0.446192,"eighty":-0.283973,"high":-0.146331,"avg":-1.480462,"sd":2.416526,"marketCap":5007561},"quantilePoints":[{"date":"2024-02-02","current":-13.016254,"twenty":-12.020228,"median":-11.748584,"eighty":-11.445249,"marketCap":105524350},{"date":"2024-02-09","current":-11.884406,"twenty":-12.744611,"median":-12.008909,"eighty":-11.694255,"marketCap":96348320},{"date":"2024-02-16","current":-6.689828,"twenty":-12.495604,"median":-11.748584,"eighty":-9.339123,"marketCap":71417101},{"date":"2024-02-23","current":-7.08358,"twenty":-12.26018,"median":-11.476941,"eighty":-6.778064,"marketCap":75620597},{"date":"2024-03-01","current":-7.048515,"twenty":-11.984009,"median":-8.871831,"eighty":-6.901819,"marketCap":75246257},{"date":"2024-03-08","current":-5.374358,"twenty":-11.816495,"median":-7.647447,"eighty":-6.67112,"marketCap":57373836},{"date":"2024-03-15","current":-6.149675,"twenty":-11.757639,"median":-7.066047,"eighty":-6.204039,"marketCap":65650718},{"date":"2024-03-22","current":-5.709154,"twenty":-11.585598,"median":-6.945107,"eighty":-5.652767,"marketCap":60947944},{"date":"2024-03-28","current":-4.880974,"twenty":-11.476941,"median":-6.748784,"eighty":-5.465987,"marketCap":52106730},{"date":"2024-04-05","current":-4.889785,"twenty":-11.413557,"median":-6.607817,"eighty":-5.286254,"marketCap":52200785},{"date":"2024-04-12","current":-4.880974,"twenty":-10.76614,"median":-6.240281,"eighty":-5.025465,"marketCap":52106730},{"date":"2024-04-19","current":-5.021941,"twenty":-9.08499,"median":-5.876552,"eighty":-4.990224,"marketCap":53611617},{"date":"2024-04-26","current":-5.867918,"twenty":-7.772626,"median":-5.709154,"eighty":-5.022575,"marketCap":62642824},{"date":"2024-05-03","current":-5.744396,"twenty":-7.692486,"median":-5.744396,"eighty":-5.029941,"marketCap":61324166},{"date":"2024-05-10","current":-5.356737,"twenty":-7.527625,"median":-5.691533,"eighty":-5.029941,"marketCap":57185725},{"date":"2024-05-17","current":-4.440453,"twenty":-7.242168,"median":-5.559377,"eighty":-4.958506,"marketCap":47403956},{"date":"2024-05-24","current":-4.211382,"twenty":-7.069554,"median":-5.492065,"eighty":-4.893239,"marketCap":44958514},{"date":"2024-05-31","current":-3.735619,"twenty":-7.037907,"median":-5.4096,"eighty":-4.852781,"marketCap":39879519},{"date":"2024-06-07","current":-2.194993,"twenty":-6.985402,"median":-5.365547,"eighty":-4.757628,"marketCap":33859969},{"date":"2024-06-14","current":-1.881328,"twenty":-6.945107,"median":-5.322641,"eighty":-4.687145,"marketCap":29021367},{"date":"2024-06-21","current":-1.404888,"twenty":-6.858532,"median":-5.286254,"eighty":-4.366446,"marketCap":21671800},{"date":"2024-06-28","current":-1.233858,"twenty":-6.819267,"median":-5.285373,"eighty":-4.133851,"marketCap":19033494},{"date":"2024-07-05","current":-0.783683,"twenty":-6.748784,"median":-5.275417,"eighty":-3.96469,"marketCap":12089095},{"date":"2024-07-12","current":-0.708552,"twenty":-6.689828,"median":-5.178943,"eighty":-2.487659,"marketCap":10930125},{"date":"2024-07-15","current":-0.754975,"twenty":-6.680474,"median":-5.144494,"eighty":-2.429126,"marketCap":11646237},{"date":"2024-08-02","current":-1.258291,"twenty":-6.67112,"median":-5.110045,"eighty":-2.392543,"marketCap":19410395},{"date":"2024-08-09","current":-0.8185,"twenty":-6.614866,"median":-5.031544,"eighty":-1.746948,"marketCap":12626179},{"date":"2024-08-16","current":-0.678902,"twenty":-6.530286,"median":-4.969079,"eighty":-1.566951,"marketCap":11717848},{"date":"2024-08-23","current":-0.808829,"twenty":-6.376223,"median":-4.933837,"eighty":-1.243631,"marketCap":13960381},{"date":"2024-08-30","current":-0.766385,"twenty":-6.204039,"median":-4.889785,"eighty":-0.908657,"marketCap":13227806},{"date":"2024-09-06","current":-1.163592,"twenty":-6.121482,"median":-4.880974,"eighty":-0.908419,"marketCap":20083598},{"date":"2024-09-13","current":-1.145173,"twenty":-5.991088,"median":-4.786791,"eighty":-0.966143,"marketCap":19765688},{"date":"2024-09-20","current":-0.869424,"twenty":-5.91708,"median":-4.757628,"eighty":-0.931248,"marketCap":15006258},{"date":"2024-09-27","current":-0.782135,"twenty":-5.89597,"median":-4.695956,"eighty":-0.867778,"marketCap":13499642},{"date":"2024-10-04","current":-0.775461,"twenty":-5.864359,"median":-4.440453,"eighty":-0.840755,"marketCap":13384458},{"date":"2024-10-11","current":-0.783603,"twenty":-5.828976,"median":-4.162925,"eighty":-0.815034,"marketCap":13524983},{"date":"2024-10-18","current":-0.767453,"twenty":-5.744396,"median":-4.017553,"eighty":-0.801154,"marketCap":13246236},{"date":"2024-10-25","current":-0.660676,"twenty":-5.737348,"median":-3.682756,"eighty":-0.798098,"marketCap":11403275},{"date":"2024-10-31","current":-0.683366,"twenty":-5.709154,"median":-2.900189,"eighty":-0.790143,"marketCap":11794903},{"date":"2024-11-08","current":-0.788474,"twenty":-5.691533,"median":-2.37791,"eighty":-0.788808,"marketCap":13609060},{"date":"2024-11-15","current":-0.785853,"twenty":-5.608715,"median":-1.832463,"eighty":-0.788808,"marketCap":11023166},{"date":"2024-11-22","current":-1.110505,"twenty":-5.568187,"median":-1.722515,"eighty":-0.788808,"marketCap":15577054},{"date":"2024-11-29","current":-0.404119,"twenty":-5.554091,"median":-1.649216,"eighty":-0.787206,"marketCap":5668573},{"date":"2024-12-06","current":-0.296518,"twenty":-5.550567,"median":-1.386563,"eighty":-0.783683,"marketCap":4159257},{"date":"2024-12-13","current":-0.258735,"twenty":-5.503765,"median":-1.233858,"eighty":-0.781801,"marketCap":3629269},{"date":"2024-12-20","current":-0.246414,"twenty":-5.426093,"median":-1.173656,"eighty":-0.779652,"marketCap":3456447},{"date":"2024-12-27","current":-0.286661,"twenty":-5.4096,"median":-1.162724,"eighty":-0.772476,"marketCap":4021000},{"date":"2025-01-03","current":-0.276805,"twenty":-5.402552,"median":-1.152867,"eighty":-0.766812,"marketCap":3882742},{"date":"2025-01-10","current":-0.234915,"twenty":-5.388455,"median":-1.126704,"eighty":-0.721272,"marketCap":3295146},{"date":"2025-01-17","current":-0.234915,"twenty":-5.370834,"median":-1.094455,"eighty":-0.690174,"marketCap":3295146},{"date":"2025-01-24","current":-0.245592,"twenty":-5.356737,"median":-1.065091,"eighty":-0.664926,"marketCap":3444925},{"date":"2025-01-31","current":-0.250521,"twenty":-5.323786,"median":-0.993874,"eighty":-0.650158,"marketCap":3514054},{"date":"2025-02-07","current":-0.223415,"twenty":-5.321496,"median":-0.95965,"eighty":-0.514527,"marketCap":3133845},{"date":"2025-02-14","current":-0.234093,"twenty":-5.286254,"median":-0.921104,"eighty":-0.367978,"marketCap":3283624},{"date":"2025-02-21","current":-0.529577,"twenty":-5.286254,"median":-0.884394,"eighty":-0.396891,"marketCap":7216540},{"date":"2025-02-28","current":-0.51331,"twenty":-5.284844,"median":-0.870433,"eighty":-0.404119,"marketCap":6994871},{"date":"2025-03-07","current":-0.451857,"twenty":-5.282659,"median":-0.864124,"eighty":-0.424958,"marketCap":6157457},{"date":"2025-03-14","current":-0.370523,"twenty":-5.271347,"median":-0.855149,"eighty":-0.404119,"marketCap":5049115},{"date":"2025-03-21","current":-0.395827,"twenty":-5.261585,"median":-0.840795,"eighty":-0.370014,"marketCap":5393932},{"date":"2025-03-28","current":-0.345219,"twenty":-5.195119,"median":-0.827514,"eighty":-0.359722,"marketCap":4704297},{"date":"2025-04-04","current":-0.301841,"twenty":-5.123825,"median":-0.816667,"eighty":-0.342327,"marketCap":4113181},{"date":"2025-04-11","current":-0.296418,"twenty":-5.095949,"median":-0.808829,"eighty":-0.326745,"marketCap":4039292},{"date":"2025-04-17","current":-0.319915,"twenty":-5.060707,"median":-0.801955,"eighty":-0.319099,"marketCap":4359479},{"date":"2025-04-25","current":-0.35534,"twenty":-5.029941,"median":-0.800887,"eighty":-0.320999,"marketCap":4842224},{"date":"2025-05-02","current":-0.413901,"twenty":-5.022575,"median":-0.797617,"eighty":-0.323356,"marketCap":5640231},{"date":"2025-05-09","current":-0.307263,"twenty":-4.990224,"median":-0.789475,"eighty":-0.323356,"marketCap":4187071},{"date":"2025-05-16","current":-0.343411,"twenty":-4.958506,"median":-0.788474,"eighty":-0.320999,"marketCap":4679667},{"date":"2025-05-23","current":-0.332567,"twenty":-4.951458,"median":-0.785996,"eighty":-0.321722,"marketCap":4531888},{"date":"2025-05-30","current":-0.301841,"twenty":-4.937361,"median":-0.783988,"eighty":-0.317967,"marketCap":4113181},{"date":"2025-06-06","current":-0.336289,"twenty":-4.909097,"median":-0.783603,"eighty":-0.31883,"marketCap":3837062},{"date":"2025-06-13","current":-0.333852,"twenty":-4.894965,"median":-0.781726,"eighty":-0.320638,"marketCap":3809257},{"date":"2025-06-20","current":-0.292426,"twenty":-4.888023,"median":-0.781,"eighty":-0.31701,"marketCap":3336576},{"date":"2025-06-27","current":-0.30461,"twenty":-4.880974,"median":-0.775594,"eighty":-0.314854,"marketCap":3475600},{"date":"2025-07-03","current":-0.346037,"twenty":-4.880974,"median":-0.774126,"eighty":-0.3163,"marketCap":3948281},{"date":"2025-07-11","current":-0.367969,"twenty":-4.845733,"median":-0.767586,"eighty":-0.3163,"marketCap":4198524},{"date":"2025-07-18","current":-0.402085,"twenty":-4.801681,"median":-0.754975,"eighty":-0.316794,"marketCap":4587792},{"date":"2025-07-25","current":-0.350911,"twenty":-4.771901,"median":-0.713978,"eighty":-0.317874,"marketCap":4003891},{"date":"2025-08-01","current":-0.350911,"twenty":-4.757628,"median":-0.696046,"eighty":-0.317874,"marketCap":4003891},{"date":"2025-08-08","current":-0.302173,"twenty":-4.757628,"median":-0.681134,"eighty":-0.316794,"marketCap":3447795},{"date":"2025-08-15","current":-0.260785,"twenty":-4.740008,"median":-0.660908,"eighty":-0.314493,"marketCap":3141942},{"date":"2025-08-22","current":-0.337222,"twenty":-4.704766,"median":-0.65435,"eighty":-0.314493,"marketCap":4062851},{"date":"2025-08-29","current":-0.515256,"twenty":-4.687145,"median":-0.552729,"eighty":-0.314493,"marketCap":6207806},{"date":"2025-09-05","current":-0.503546,"twenty":-4.517985,"median":-0.552729,"eighty":-0.315939,"marketCap":6066719},{"date":"2025-09-12","current":-0.543361,"twenty":-4.447501,"median":-0.545703,"eighty":-0.3163,"marketCap":6546413},{"date":"2025-09-19","current":-0.517853,"twenty":-4.41226,"median":-0.548045,"eighty":-0.316695,"marketCap":6239091},{"date":"2025-09-26","current":-0.507989,"twenty":-4.250148,"median":-0.545403,"eighty":-0.317658,"marketCap":6120251},{"date":"2025-10-03","current":-0.577036,"twenty":-4.133851,"median":-0.543361,"eighty":-0.31806,"marketCap":6952130},{"date":"2025-10-10","current":-0.621423,"twenty":-4.079226,"median":-0.547745,"eighty":-0.319006,"marketCap":7486909},{"date":"2025-10-17","current":-0.547444,"twenty":-4.028125,"median":-0.547444,"eighty":-0.319231,"marketCap":6595611},{"date":"2025-10-24","current":-0.552376,"twenty":-3.975263,"median":-0.547745,"eighty":-0.319778,"marketCap":6655031},{"date":"2025-10-31","current":-0.507989,"twenty":-3.781433,"median":-0.547444,"eighty":-0.321317,"marketCap":6120251},{"date":"2025-11-07","current":-0.424343,"twenty":-3.651039,"median":-0.547444,"eighty":-0.321711,"marketCap":5112489},{"date":"2025-11-14","current":-0.360179,"twenty":-3.376154,"median":-0.547444,"eighty":-0.321722,"marketCap":4339436},{"date":"2025-11-21","current":-0.411623,"twenty":-2.652671,"median":-0.543361,"eighty":-0.321722,"marketCap":6870808},{"date":"2025-11-28","current":-0.441452,"twenty":-2.443759,"median":-0.538098,"eighty":-0.322807,"marketCap":7368713},{"date":"2025-12-05","current":-0.358937,"twenty":-2.392543,"median":-0.532649,"eighty":-0.324079,"marketCap":5991383},{"date":"2025-12-12","current":-0.318981,"twenty":-2.26816,"median":-0.5271,"eighty":-0.322807,"marketCap":5324438},{"date":"2025-12-19","current":-0.261045,"twenty":-2.006794,"median":-0.522785,"eighty":-0.319641,"marketCap":4357363},{"date":"2025-12-26","current":-0.247554,"twenty":-1.842236,"median":-0.522785,"eighty":-0.318457,"marketCap":4132172},{"date":"2026-01-02","current":-0.227607,"twenty":-1.771381,"median":-0.519933,"eighty":-0.316399,"marketCap":3799222},{"date":"2026-01-09","current":-0.206171,"twenty":-1.722515,"median":-0.517853,"eighty":-0.314493,"marketCap":3441405},{"date":"2026-01-16","current":-0.215317,"twenty":-1.712139,"median":-0.515826,"eighty":-0.308968,"marketCap":3594064},{"date":"2026-01-23","current":-0.195039,"twenty":-1.670634,"median":-0.515117,"eighty":-0.307047,"marketCap":3255588},{"date":"2026-01-30","current":-0.165533,"twenty":-1.649216,"median":-0.51331,"eighty":-0.30461,"marketCap":2763071},{"date":"2026-02-06","current":-0.146331,"twenty":-1.512107,"median":-0.507989,"eighty":-0.302173,"marketCap":2442554},{"date":"2026-02-13","current":-0.152257,"twenty":-1.404888,"median":-0.505768,"eighty":-0.297322,"marketCap":2624917},{"date":"2026-02-20","current":-0.248372,"twenty":-1.375569,"median":-0.497584,"eighty":-0.296274,"marketCap":4281926},{"date":"2026-02-27","current":-0.27127,"twenty":-1.280281,"median":-0.492828,"eighty":-0.292426,"marketCap":4676690},{"date":"2026-03-06","current":-0.27577,"twenty":-1.238745,"median":-0.476714,"eighty":-0.290136,"marketCap":4754273},{"date":"2026-03-13","current":-0.279277,"twenty":-1.220142,"median":-0.451857,"eighty":-0.284757,"marketCap":4814743},{"date":"2026-03-20","current":-0.275307,"twenty":-1.182972,"median":-0.4473,"eighty":-0.283221,"marketCap":4746287},{"date":"2026-03-24","current":-0.290462,"twenty":-1.174185,"median":-0.446192,"eighty":-0.283973,"marketCap":5007561}],"updateTime":1774446476980},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMIX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2618541947","title":"Autonomix Medical CEO Brad Hauser to Present at LSI USA ’26","url":"https://stock-news.laohu8.com/highlight/detail?id=2618541947","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618541947?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:41","pubTimestamp":1773232887,"startTime":"0","endTime":"0","summary":"Autonomix will present at LSI USA ’26 on March 17, 2026 at 9:15 AM PT. Management plans to hold in-person one-on-one meetings with registered, qualified investors during the conference. The presentation is available to registered attendees via the conference website.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nNDLYl7w0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4112","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","BK4082","AMIX","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2617528901","title":"Autonomix Medical Selected for Best Innovation Competition at CRT 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528901","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617528901?lang=en_us&edition=fundamental","pubTime":"2026-03-05 21:45","pubTimestamp":1772718300,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, March  05, 2026  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/05/3250194/0/en/Autonomix-Medical-Selected-for-Best-Innovation-Competition-at-CRT-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","BK4082","CRT","AMIX"],"gpt_icon":0},{"id":"2616360555","title":"Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2616360555","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616360555?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:40","pubTimestamp":1772631616,"startTime":"0","endTime":"0","summary":"Autonomix Medical to Present Top Abstract Podium at CRT 2026 Meeting               Autonomix Medical Inc. said Nikola Cesarovic, PhD, will present clinical feasibility and early outcomes data at the C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260304:nNDLc6kQL4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMIX","BK4082","SG9999014039.USD","LU0314104364.USD","LU2210150020.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00B64PRP62.GBP","LU2095319765.USD","LU2210149790.SGD","SG9999014005.SGD","BK4588","BK4112","NDAQ","IE00BKPKM429.USD","BK4585","SG9999014013.SGD"],"gpt_icon":0},{"id":"2616555027","title":"Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2616555027","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616555027?lang=en_us&edition=fundamental","pubTime":"2026-03-04 21:40","pubTimestamp":1772631600,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, March  04, 2026  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc.(NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/04/3249381/0/en/Autonomix-Medical-Selected-as-Top-Abstract-at-CRT-2026-and-Selected-for-Podium-Presentation-of-Clinical-Feasibility-and-Outcomes-of-Novel-Technique-for-Transvascular-Peripheral-RF-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRT","BK4588","RF","BK4082","BK4211","LU1883839398.USD","LU1880398554.USD","AMIX","BK4585","LU1880398471.USD","BK4213"],"gpt_icon":0},{"id":"2614080749","title":"BRIEF-Autonomix Medical Announces Release Of New CEO Corner Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2614080749","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614080749?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:53","pubTimestamp":1772027599,"startTime":"0","endTime":"0","summary":"BRIEF-Autonomix Medical Announces Release Of New CEO Corner SegmentFeb 25 (Reuters) - Autonomix Medical Inc AMIX.O:AUTONOMIX MEDICAL ANNOUNCES RELEASE OF NEW CEO CORNER SEGMENT HIGHLIGHTING PUBLICATIO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nTUA45TGKB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2614208701","title":"Autonomix Medical CEO Brad Hauser Highlights Publication Strategy and Scientific Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=2614208701","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614208701?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:31","pubTimestamp":1772026279,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. released a new CEO Corner segment featuring President and CEO Brad Hauser, who discusses the company’s publication strategy and its push over the past 12 to 18 months to expand scientific publications and presentations. Hauser said submitting clinical and technical data to competitive, peer-reviewed forums is key to validating Autonomix’s technology, strengthening clinical credibility, and supporting long-term growth. The segment can be accessed via the CEO Corner section of the company’s website.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDL1KL2Tk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BGHQF748.EUR","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","BK4112","IE00B64PRP62.GBP","LU2095319765.USD","SG9999014013.SGD","LU2210150020.SGD","BK4588","NDAQ","AMIX","SG9999014005.SGD","BK4082","LU0314104364.USD","SG9999014039.USD","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2612007524","title":"Autonomix Medical to Present Long-Term Pancreatic Cancer Pain Data at SSO 2026 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2612007524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612007524?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:30","pubTimestamp":1771507819,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire  on February 19, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL7Xtc2d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD","LU0314104364.USD","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","BK4585","BK4112","LU2095319765.USD","LU2210149790.SGD","AMIX","IE00BKPKM429.USD","BK4082","SG9999014039.USD","SG9999014013.SGD"],"gpt_icon":0},{"id":"2612742462","title":"Autonomix Medical Is Maintained at Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2612742462","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612742462?lang=en_us&edition=fundamental","pubTime":"2026-02-18 04:12","pubTimestamp":1771359120,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMIX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 17, 2026 15:12 ET (20:12 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2606110327","title":"Autonomix Medical Unveils Final Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at SIO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2606110327","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606110327?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:30","pubTimestamp":1769607034,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has announced that final clinical data evaluating its transvascular radiofrequency  ablation approach for pain mitigation in patients with pancreatic adenocarcinoma will be presented at the Society of Interventional Oncology  2026 Annual Scientific Meeting, scheduled to take place February 4-8, 2026, in Savannah, Georgia. The presentation, titled \"Pain Mitigation in Pancreatic Adenocarcinoma: A Final Analysis of Neurolysis via Transvascular Radiofrequency  Ablation,\" will be delivered as an ePoster by Clarke Wilkirson, PhD, on February 6, 2026, during the Science and Sips Reception. The results have not yet been presented and will be shared at the upcoming meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nNDL4DWKQF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","BK4112","SG9999014005.SGD","AMIX","IE00B3QW5Z07.USD","SG9999014021.USD","NDAQ","BK4585","IE00B64PRP62.GBP","LU0314104364.USD","LU2095319765.USD","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4082"],"gpt_icon":0},{"id":"2603199306","title":"Autonomix Medical Faces Nasdaq Delisting Risk Over Low Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2603199306","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603199306?lang=en_us&edition=fundamental","pubTime":"2026-01-16 20:31","pubTimestamp":1768566664,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has received a deficiency letter from the Nasdaq Stock Market after its common stock closed below the minimum $1.00 per share requirement for 30 consecutive business days, violating Nasdaq Listing Rule 5550. The company has until July 13, 2026, to regain compliance or risk delisting from the Nasdaq Capital Market. Potential remedies to meet the listing requirement, such as a reverse stock split, are being considered, but there is no assurance of regaining compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchang","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDL6lcBjh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2602371368","title":"Autonomix showcases PoC study clinical data at 2026 ASCO Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2602371368","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602371368?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:51","pubTimestamp":1767966686,"startTime":"0","endTime":"0","summary":"Autonomix (AMIX) Medical announced new subgroup clinical data from its PoC study presented at the 2026 ASCO Gastrointestinal Cancers Symposium demo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-showcases-poc-study-clinical-data-at-2026-asco-symposium-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-showcases-poc-study-clinical-data-at-2026-asco-symposium-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2602379103","title":"Autonomix Medical Reports Durable Pain Relief in Pancreatic Cancer Across All Stages","url":"https://stock-news.laohu8.com/highlight/detail?id=2602379103","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602379103?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:45","pubTimestamp":1767966311,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. announced new subgroup clinical data from its proof-of-concept study, which was presented at the 2026 ASCO Gastrointestinal  Cancers Symposium. The data demonstrated rapid, durable, and clinically meaningful pain relief in pancreatic cancer patients across all disease stages, from Stage 2 through Stage 4, including those with limited treatment options. The findings were shared during Poster Session B under the title \"Pain mitigation in pancreatic adenocarcinoma: A long-term analysis of denervation via transvascular RF energy-based ablation\" by Dr. Robert S. Schwartz, Chief Medical Officer of Autonomix Medical. The dataset included patients with severe pancreatic cancer-related pain, and the subgroup analysis expanded upon previously reported results from the company’s ongoing clinical evaluation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL8nCJH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","IE00B64PRP62.GBP","IE00BGHQF748.EUR","SG9999014005.SGD","BK4112","NDAQ","SG9999014013.SGD","LU2210149790.SGD","SG9999014039.USD","IE00B3QW5Z07.USD","BK4082","LU2210150020.SGD","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","AMIX","SG9999014021.USD"],"gpt_icon":0},{"id":"2595704797","title":"Autonomix Medical, Inc. Granted European Patent on Platform Technology Enabling Precision Nerve-Targeted Therapies in Cardiology","url":"https://stock-news.laohu8.com/highlight/detail?id=2595704797","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595704797?lang=en_us&edition=fundamental","pubTime":"2025-12-30 21:30","pubTimestamp":1767101453,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nFWN3Y00FG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2595179709","title":"Autonomix Medical Granted European Patent for Precision Nerve-Targeted Cardiac Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2595179709","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595179709?lang=en_us&edition=fundamental","pubTime":"2025-12-30 21:30","pubTimestamp":1767101412,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has been granted European Patent No. EP4230133, titled \"Controlled and Precise Treatment of Cardiac Tissues.\" The patent covers systems, devices, and methods for sensing autonomic and cardiac signals, mapping targets, and delivering therapy with closed-loop feedback to precisely treat cardiac tissues through feedback-driven neuromodulation, denervation, and ablation. This new patent strengthens the company’s intellectual property portfolio and supports its strategy to provide precision nerve-targeted therapies in high-growth areas such as cardiology and resistant hypertension.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251230:nNDLtLqbX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014013.SGD","LU2210150020.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","AMIX","SG9999014021.USD","BK4588","NDAQ","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","IE00BGHQF748.EUR","SG9999014039.USD","BK4082","BK4585","BK4112","LU2210149790.SGD","LU2095319765.USD"],"gpt_icon":0},{"id":"2593941336","title":"Autonomix CEO Highlights IP Expansion and New Indications in Virtual Investor Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=2593941336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593941336?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:45","pubTimestamp":1766497507,"startTime":"0","endTime":"0","summary":"Autonomix Medical, Inc. , a medical device company focused on advancing precision nerve-targeted treatments, recently participated in a Virtual Investor CEO Connect segment. During the event, CEO Brad Hauser highlighted the company's commitment to expanding its intellectual property portfolio and exploring multi-indication opportunities for its platform technology, which includes a catheter-based microchip sensing array aimed at improving the diagnosis and treatment of diseases involving the nervous system. Hauser discussed the company's initial focus on pain management, particularly in pancreatic cancer, and emphasized potential future applications in cardiovascular, pulmonary, and interventional pain management. The Virtual Investor CEO Connect segment is now available here.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for information","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL7dj0s3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","IE00B64PRP62.GBP","SG9999014039.USD","BK4585","LU2210149790.SGD","BK4112","LU2210150020.SGD","LU2095319765.USD","SG9999014005.SGD","LU0314104364.USD","BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","NDAQ","SG9999014021.USD","BK4082","AMIX","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2592909572","title":"Autonomix Medical Showcases Long-Term Pancreatic Cancer Pain Study at 2026 ASCO Symposium","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909572","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909572?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:30","pubTimestamp":1766064628,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has announced that its abstract titled \"Pain mitigation in pancreatic adenocarcinoma: A long-term analysis of denervation via transvascular RF energy-based ablation\" has been accepted for poster presentation at the 2026 American Society of Clinical Oncology  Gastrointestinal Cancers Symposium. The presentation, to be delivered by Chief Medical Officer Robert S. Schwartz, MD, will take place on January 9, 2026, in San Francisco, California. The results of the study will be presented at the symposium and have not yet been disclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire  on December 18, 2025, and is sol","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL9gH76V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4082","NDAQ","SG9999014021.USD","IE00BKPKM429.USD","BK4585","IE00BGHQF748.EUR","LU0314104364.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BK4112","AMIX","LU2210150020.SGD","LU2095319765.USD","SG9999014039.USD","SG9999014005.SGD"],"gpt_icon":0},{"id":"2586110293","title":"Autonomix files to sell 13.5M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2586110293","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586110293?lang=en_us&edition=fundamental","pubTime":"2025-11-27 06:10","pubTimestamp":1764195011,"startTime":"0","endTime":"0","summary":"This offering relates to the resale by the selling stockholder of up to an aggregate of 9,003,332 shares of Autonomix (AMIX) common stock issuable ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-files-to-sell-13-5m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-files-to-sell-13-5m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMIX","BK4082"],"gpt_icon":0},{"id":"2586250635","title":"Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2586250635","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586250635?lang=en_us&edition=fundamental","pubTime":"2025-11-26 21:45","pubTimestamp":1764164700,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, TX, Nov.  26, 2025  (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/26/3195151/0/en/Autonomix-Medical-Inc-NASDAQ-AMIX-Announces-Release-of-the-Next-CEO-Corner-Segment-Highlighting-Continued-Execution-and-Strategic-Growth.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SQQQ","AMIX","TSYW.SI","MNQmain","NVIW.SI","BK4082","PSQ","TQQQ",".IXIC","QLD","USJW.SI","USAW.SI","NQmain","QID"],"gpt_icon":1},{"id":"2584959303","title":"Autonomix prices 4.5M shares at $1.11 in private placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2584959303","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584959303?lang=en_us&edition=fundamental","pubTime":"2025-11-18 23:00","pubTimestamp":1763478039,"startTime":"0","endTime":"0","summary":"Autonomix (AMIX) Medical entered into a securities purchase agreement with a single institutional investor to purchase 4,501,666 shares of common s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autonomix-prices-4-5m-shares-at-1-11-in-private-placement-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autonomix-prices-4-5m-shares-at-1-11-in-private-placement-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","AMIX"],"gpt_icon":0},{"id":"2584958800","title":"Autonomix Medical Raises $5 Million in Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2584958800","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584958800?lang=en_us&edition=fundamental","pubTime":"2025-11-18 21:34","pubTimestamp":1763472851,"startTime":"0","endTime":"0","summary":"Autonomix Medical Inc. has announced a private placement with a single institutional investor, raising approximately $5.0 million through the sale of 4,501,666 shares of common stock  and unregistered Series C warrants to purchase up to 9,003,332 shares of common stock. The combined offering price is $1.1107 per share and accompanying warrant, with each Series C warrant carrying an exercise price of $0.8607 per share, exercisable immediately and expiring five and a half years from issuance. The securities are being sold under Section 4 and/or Regulation D and are not registered under the Securities Act. Autonomix has agreed to file a registration statement to register the resale of the securities. Maxim Group LLC is serving as the sole placement agent for the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL6Vzdy3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","AMIX"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":33,"code":"91000000","status":"200"}]}}